What is Agios Pharmaceuticals's treasury stock?

Agios Pharmaceuticals (AGIO) reported treasury stock of $802.49M in Q1 2026.

How has Agios Pharmaceuticals's treasury stock changed year-over-year?

Agios Pharmaceuticals's treasury stock decreased by 0.0% year-over-year, from $802.49M to $802.49M.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Agios Pharmaceuticals AGIO Treasury Stock

Treasury Stock at other companies

Bristol-Myers SquibbBMY

$43.52B-0.2%

PfizerPFE

$115.19B+0.2%

Ultragenyx PharmaceuticalRARE

$10M+32.2%

ANI PharmaceuticalsANIP

$53M+70.7%

CRISPR TherapeuticsCRSP

$60K-3.2%

BridgeBio PharmaBBIO

$405.78M+25.5%

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.16B+18.1%

Enterprise value$2.08B+15.2%

P/S32.7×-16.7×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's treasury stock?: Agios Pharmaceuticals (AGIO) reported treasury stock of $802.49M in Q1 2026.
How has Agios Pharmaceuticals's treasury stock changed year-over-year?: Agios Pharmaceuticals's treasury stock decreased by 0.0% year-over-year, from $802.49M to $802.49M.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.